| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Satellogic Inc.
13D/A
SATL · G7823S101
|
0% |
3/26/2026
Event 3/24/2026
|
||||
|
M3-Brigade Acquisition V Corp.
13D/A
VLOS · G63212107
|
27.1% |
3/2/2026
Event 2/26/2026
|
||||
| Cantor Fitzgerald, L.P. | 27.1% | |||||
| CF Group Management, Inc. | 27.1% | |||||
| Cantor Fitzgerald & Co. | 27.1% | |||||
| Cantor Fitzgerald Securities | 27.1% | |||||
| Brandon Lutnick | 27.1% | |||||
| Schedule 13G · 2 securities · passive | ||||||
|
Sono Group N.V.
13G
SEVCF · N81409109
|
7.0% |
2/13/2026
Event 9/30/2025
|
||||
| Cantor Fitzgerald Securities | 7.0% | |||||
| Cantor Fitzgerald & Co. | 7.0% | |||||
| Cantor Fitzgerald, L.P. | 7.0% | |||||
| CF Group Management, Inc. | 7.0% | |||||
| Brandon G. Lutnick | 7.0% | |||||
|
OnKure Therapeutics Inc.
13G
OKUR · 68277Q105
|
5.2% |
8/14/2025
Event 6/30/2025
|
||||
| Cantor Fitzgerald Securities | 5.2% | |||||
| Cantor Fitzgerald & Co. | 5.2% | |||||
| Cantor Fitzgerald, L.P. | 5.2% | |||||
| CF Group Management, Inc. | 5.2% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.